期刊文献+

Effect of recombinant human brain natriuretic peptide on serum inflammatory factors, neuroendocrine hormones and cardiac function in patients with acute myocardial infarction complicated with heart failure

下载PDF
导出
摘要 Objective:To investigate the effect of recombinant human brain natriuretic peptide (BNP) on inflammatory factors, neuroendocrine hormones and cardiac function indexes in patients with acute myocardial infarction complicated with heart failure.Methods:A total of91 cases of acute myocardial infarction with heart failure patients were divided into the control group (n=44) and observation group (n=47) according to the random data table, two groups of patients were given conventional treatment, based on this, the control group was given intravenous infusion of Nitroglycerin Injection treatment, the observation group received intravenous injection of recombinant human brain natriuretic peptide treatment, compared serum inflammatory factors, neuroendocrine hormone and cardiac function and other indexes of two groups before and after treatment.Results: there was no significant difference between the two groups before treatment. After treatment, the levels of TNF-α, hs-CRP, IL-6, MCP-1, LVESD and LVEDD in the two groups were significantly lower than those within the group before treatment, and the observation group was significantly lower than the control group;The two groups after treatment LVEF levels were significantly higher than those in the group before treatment, and the observation group was significantly higher than that of control group;the observation group after treatment PRA, Ang II and ALD and NE levels were significantly lower than those before treatment, and was significantly lower than the control group after treatment, the difference was significant, PRA, Ang, ALD and NE levels of control group before and after the treatment was no significant difference.Conclusion:recombinant human brain natriuretic peptide in the treatment of acute myocardial infarction with heart failure can effectively reduce the serum inflammatory factors and neuroendocrine hormone levels, improve heart function, and have a certain clinical value.
出处 《Journal of Hainan Medical University》 2017年第13期14-17,共4页 海南医学院学报(英文版)
基金 Basic Research Program of Jiangsu Province(Natural Science Foundation of China)(BK2015125).
  • 相关文献

参考文献7

二级参考文献80

  • 1Ana B Méndez,Jordi Ordonez-Llanos,Andreu Ferrero,Mariana Noguero,Teresa Mir,Josefina Mora,Antoni Bayes-Genis,Sònia Mirabet,Juan Cinca,Eulàlia Roig.Prognostic value of increased carbohydrate antigen in patients with heart failure[J].World Journal of Cardiology,2014,6(4):205-212. 被引量:13
  • 2陈华,王晓惠,金伟华.新活素[J].中国新药杂志,2006,15(5):393-394. 被引量:38
  • 3李帮清,杨莉军,胡大一,吴淳,徐成斌.血清肌酐水平对急性心肌梗死患者预后的影响[J].中华内科杂志,2006,45(7):544-547. 被引量:19
  • 4叶任高,主编.内科学[M]第6版.北京:人民卫生出版社,2005.57.
  • 5Balion C M, Santaguida P, McKelvie R, et al. Physiological, pathological, pharmacological, biochemical and hematologica factors affecting BNP and NT-pro BNP [J]. Clin Biochem, 2008, 41(4/5): 231-239.
  • 6Silver M A, Horton D P, Chali J K, et al. Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure [J]. JAm Coll Cardiol, 2002, 39(5): 798-803.
  • 7Tanner H, Mohacsi P, Bicer G A, et al. Cytokine activation and disease progression in patients with stable moderate chronic heart failure [J]. J Heart Lung Transplant, 2007, 26(6): 622-629.
  • 8Kramer B K, Endemann D. Cardiac risks of hypokalemia and hypomagnesemia [J]. Ther Umsch, 2000, 57 (6):398-399.
  • 9Jiang Z,Seo JY,Ha H,et al.Reactive oxygen species me-diate TGF-betal-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells[J].Biochem Biophys Res Commun,2003,309(4):961-966.
  • 10Prodjosudjadi W,Gerritsma JS,van Es LA,et al.Monocyte chenoattractant protein-1 in normal and diseased human kid-neys:an immunohistochemical analysis [ J].Clin Nephrol,1995,44(3):148-155.

共引文献130

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部